Chemomab Therapeutics Ltd Stock Performance

Chemomab Therapeutics Relative Risk vs. Return Landscape

If you would invest  280.00  in Chemomab Therapeutics Ltd on November 1, 2025 and sell it today you would lose (118.00) from holding Chemomab Therapeutics Ltd or give up 42.14% of portfolio value over 90 days. Chemomab Therapeutics Ltd is currently does not generate positive expected returns and assumes 4.1928% risk (volatility on return distribution) over the 90 days horizon. In different words, 37% of stocks are less volatile than Chemomab, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.Given the investment horizon of 90 days Chemomab Therapeutics is expected to under-perform the market. In addition to that, the company is 5.58 times more volatile than its market benchmark. It trades about -0.2 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.08 per unit of volatility.

Chemomab Therapeutics Target Price Odds to finish over Current Price

Given the investment horizon of 90 days Chemomab Therapeutics has a beta of 0.0808 suggesting as returns on the market go up, Chemomab Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Chemomab Therapeutics Ltd will be expected to be much smaller as well. Additionally Chemomab Therapeutics Ltd has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.

Predictive Modules for Chemomab Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Chemomab Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.08 1.62 5.89 Details

Intrinsic Valuation Low Real High 0.08 1.60 5.87 Details

Naive Forecast Low Next High 0.03 1.48 5.75 Details

2 Analysts Consensus Low Target High 15.93 17.50 19.43 Details

Chemomab Therapeutics Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Chemomab Therapeutics is not an exception. The market had few large corrections towards the Chemomab Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Chemomab Therapeutics Ltd, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Chemomab Therapeutics within the framework of very fundamental risk indicators.

Chemomab Therapeutics Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Chemomab Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Chemomab Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Chemomab Therapeutics Price Density Drivers

Chemomab Therapeutics Fundamentals Growth

When running Chemomab Therapeutics' price analysis, check to measure Chemomab Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemomab Therapeutics is operating at the current time. Most of Chemomab Therapeutics' value examination focuses on studying past and present price action to predict the probability of Chemomab Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemomab Therapeutics' price. Additionally, you may evaluate how the addition of Chemomab Therapeutics to your portfolios can decrease your overall portfolio volatility.